Cloning and sequencing of variable region cDNAs of a novel human monoclonal antibody to carcinoembryonic antigen, and generation of a single chain variable fragmented antibody

Anticancer Research

Volumn 24, Issue 5 C, 2004, Pages 3355-3360

  Shibaguchi, Hirotomo ^a,b   Kuroki, Masahide ^a,b   Kuroki, Motomu ^a,b   Badran, Adel ^b   Hachimine, Ken ^a   Kinugasa, Tetsushi ^a,b  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

Author keywords

Carcinoembryonic antigen; Monoclonal antibody; scFv

Indexed keywords

CARCINOEMBRYONIC ANTIBODY; CARCINOEMBRYONIC ANTIGEN; COMPLEMENTARY DNA; HUMAN MONOCLONAL ANTIBODY;

ANTIBODY PRODUCTION; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; CONFERENCE PAPER; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOGLOBULIN GENE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; BASE SEQUENCE; CARCINOEMBRYONIC ANTIGEN; CLONING, MOLECULAR; DNA, COMPLEMENTARY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN VARIABLE REGION; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 6344278266     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Beverley P: Tumor immunology. In: Immunology 6th ed. (Roitt I, Brostoff J and Male D, eds). London, Mosby International Ltd, 2001, pp289-302.
2. Ishida I, Tomizuka K, Yoshida H, Tahara T, Takahashi N, Ohguma A, Tanaka S, Umehashi M, Maeda H, Nozaki C, Halk E and Lonberg N: Production of human monoclonal and polyclonal antibodies in TransChromo animals. Cloning Stem Cells 4: 91-102, 2002.
3. Buchsbaum D, Khazaeli MB, Liu T, Bright S, Richardson K, Jones M and Meredith R: Fractionated radioimmunotherapy of human colon carcinoma xenografts with 131I-labeled monoclonal antibody CC49. Cancer Res 55 (Suppl.): 5881s-5887s, 1995.
4. Imakiire T, Kuroki M, Shibaguchi H, Abe H, Yamauchi Y, Ueno A, Hirose Y, Yamada H, Yamashita Y, Shirakusa T and Ishida I: Generation, immunologic characterization and antitumor effects of human monoclonal antibodies for carcinoembryonic antigen. Int J Cancer 108: 564-570, 2004.
5. Horton RM, Hunt HD, Ho SN, Pullen JK and Pease LR: Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77: 61-68, 1989.
6. Warrens AN, Jones MD and Lechler RI: Splicing by overlap extension by PCR using asymmetric amplification: an improved technique for the generation of hybrid proteins of immunological interest. Gene 186: 29-35, 1997.
7. Arakawa F, Yamamoto T, Kanda H, Watanabe T and Kuroki M: cDNA sequence analysis of monoclonal antibody FU-MK-1 specific for a transmembrane carcinoma-associated antigen, and construction of a mouse/human chimeric antibody. Hybridoma 18: 131-138, 1999.
8. Kuroki M, Ueno A, Matsumoto H, Abe H, Li T, Imakiire T, Yamauchi Y, Uno K, Shirota K and Shibaguchi H: Significance of tumor-associated antigens in the diagnosis and therapy of cancer: an overview. Anticancer Res 22: 4255-4264, 2002.
9. Fichera A, Michelassi F and Arenas RB: Selective expression of carcinoembryonic antigen promoter in cancer cell lines: targeting strategy for gene therapy in colorectal cancer. Dis Colon Rectum 41: 747-754, 1998.
10. Benchimol S, Fuks A, Jothy S, Beauchemin N, Shirota K and Stanners CP: Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 57: 327-334, 1989.
11. Sell S: Cancer markers of the 1990s. Comparison of the new generation of markers defined by monoclonal antibodies and oncogene probes to prototypic markers. Clin Lab Med 10: 1-37, 1990.
12. Liao S, Khare PD, Arakawa F, Kuroki M, Hirose Y, Fujimura S and Tomita Y: Targeting of LAK activity to CEA-expressing tumor cells with an anti-CEA scFv/IL-2 fusion protein. Anticancer Res 21: 1673-1680, 2001.
13. Haynes NM, Snook MB, Trapani JA, Cerruti L, Jane SM, Smyth MJ and Darcy PK: Redirecting mouse CTL against colon carcinoma: superior signaling efficacy of single-chain variable domain chimeras containing TCR-zeta vs Fc epsilon RI-gamma. J Immunol 166: 182-187, 2001.
14. Khare PD, Liao S, Hirose Y, Kuroki M, Fujimura S, Yamauchi Y and Miyajima-Uchida H: Tumor growth suppression by a retroviral vector displaying scFv antibody to CEA and carrying the iNOS gene. Anticancer Res 22: 2443-2446, 2002.
15. Gyobu H, Tsuji T, Suzuki Y, Ohkuri T, Chamoto K, Kuroki M, Miyoshi H, Kawarada Y, Katoh H, Takeshima T and Nishimura T: Generation and targeting of human tumor-specific Tc1 and Th1 cells transduced with a lentivirus containing a chimeric immunoglobulin T-cell receptor. Cancer Res 64: 1490-1495, 2004.